This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Respiratory
Dual analytical approach reveals causal link between smoking and outcomes in COVID-19
Read more
Pharmacy inhaler technique service improves outcomes for asthma and COPD patients
Read more
Dupilumab added to immunotherapy of no benefit in seasonal allergic rhinitis
Read more
Monoclonal antibodies effective in eosinophilic asthma
Read more
Flu vaccination reduces infection risk and symptom burden of COVID-19
Read more
AI system detects appropriate self-medication with insulin and inhalers
Read more
Increased anxiety among asthmatics a risk factor in disease worsening during COVID-19
Read more
Respiratory tract hydration from face masks appears to protect against COVID-19
Read more
Increased risk of asthma with PPI use in children
Read more
Nebulised magnesium has no effect on hospitalisation in acute refractory asthma
Read more
Vitamin D has little impact on asthma exacerbations in high risk children
Read more
Honey better than antibiotics for upper respiratory tract infections
Read more
eNose technology helps to diagnose interstitial lung disease
Read more
Ocular allergic rhinitis symptoms equally improved by intranasal triamcinolone and fluticasone
Read more
Parents of children with asthma value written information from their specialist
Read more
COVID-19 drug trial could lead to enhanced respiratory care for patients
Read more
Are smokers protected from COVID-19?
Read more
Page 8 of 12
« First
«
...
6
7
8
9
10
...
»
Last »
Popular articles
Even light physical activity can mitigate ‘ticking time bomb’ of cardiac health, study finds
16 May, 2024
Tafamidis now available on the NHS as first approved treatment for ATTR-CM
16 May, 2024
Access to tumour profiling tests for guiding adjuvant chemotherapy decisions expanded
20 May, 2024
x
Search for: